期刊文献+

乳酸菌胞外多糖的理化特性及免疫调节机制研究进展 被引量:11

Research advances on physicochemical characterization and immunoregulatory mechanism of exopolysaccharides from Lactic acid bacteria
下载PDF
导出
摘要 乳酸菌作为公认的食品级益生菌,在医学、食品科学及人类健康中发挥重要作用。胞外多糖作为乳酸菌的主要次级代谢产物与其相应生物学功能的发挥有着密切联系。本文在综述乳酸菌胞外多糖的理化特性和免疫调节活性的前提下,从乳酸菌胞外多糖对肠道蛋白表达水平及肠道微生物菌群影响等方面入手,探讨其免疫调节相关作用机制,为研发乳酸菌胞外多糖功能食品及乳酸菌资源的高值化利用提供可靠的理论参考。 Lactic acid bacteria are acknowledged as one kind of food-grade probiotics, and play an important role in medical science, food science and many other fields of life science. Exopolysaccharides(EPSs) as the main secondary metabolites of Lactic acid bacteria are closely related to its biological characteristics. This paper mainly reviewed the physicochemical properties and immunomodulatory activity. Furthermore, the effects of EPSs form Lactic acid bacteria on the intestinal protein expression and intestinal microbial flora were reviewed to explore the immune regulation mechanism. We expect that this study will provide the theoretical basis for further research and development of EPSs functional food and for the high value of utilization of Lactic acid bacteria
作者 吴彤 房晓彬 闵伟红 王辑 WU Tong;FANG Xiaobin;MIN Weihong;WANG Ji(College of Food Science and Engineering, Jilin Agricultural UniversiW National Engineering Laboratory on Wheat and Corn Further Processing, Changchun 130118, China)
出处 《中国乳品工业》 CAS CSCD 北大核心 2018年第5期36-38,42,共4页 China Dairy Industry
基金 吉林省教育厅科学技术研究项目(JJKH20170300KJ)
关键词 乳酸菌 胞外多糖 理化特性 免疫调节 Lactic acid bacteria Exopolysaccharides Physicochemical Characterization Immunomodulatory
  • 相关文献

参考文献1

二级参考文献41

  • 1艾连中,郭本恒,张灏,陈卫,汤坚.乳酸菌胞外多糖的研究[J].乳业科学与技术,2007,29(1):1-3. 被引量:6
  • 2Lozupone CA, Stombaugh JI, Gordon JI, et al. Diversity, sta- bility and resilience of the human gut microbiota[J]. Nature, 2012, 489(7415): 220-230.
  • 3Xu X, Xu P, Ma C, et al. Gut microbiota, host health, and polysaccharides[J]. Bioteehnol Adv, 2013, 31(2): 318-337.
  • 4Wen L, Ley RE, Volchkov PY, et al. Innate immunity and in- testinal microbiota in the development of Type 1 diabetes[J]. Nature, 2008, 455(7216) : 1109-1113.
  • 5塩见道夫,佐木邦明,室伏贡,et al. Antitumor activity inmice of orally administered polysaeeharide from kefir grain[J]. Japan J Med Sci ga Biol, 1982, 35(2): 75-80.
  • 6Nagaoka M, Hashimoto S, Watanabe T, et al. Anti-ulcer effects of lactic acid bacteria and their cell wall polysaccharides[J]. Biolog Pharrnac Bull, 1994, 17(8): 1012 -1017.
  • 7Salazar N, Gueimonde M, Hem Ndez-Barranco AM, et al. Exopolysaccharides produced by intestinal Bifidobacteriurn strains act as fermentable substrates for human intestinal bac- teria[J]. Appl & Environ Microbiol, 2008, 74 (15): 4737-4745.
  • 8Jolly L, Vincent SJ, Duboc P, et al. Exploiting exopolysaccha- rides from lactic acid bacteria[J]. Antonie Van Leeuwenhoek, 2002, 82(1-4): 367-374.
  • 9De Vuyst L, Degeest B. Heteropolysaccharides from lactic acid bacteria[J]. FEMS Microbiol Rev, 1999, 23(2): 153-177.
  • 10Afrc RF. Probioties in man and animals[J]. J Appl Bacteriol, 1989, 66(5): 365-378.

共引文献14

同被引文献150

引证文献11

二级引证文献80

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部